Cargando…

Orchestrating stem cell fate: Novel tools for regenerative medicine

Mesenchymal stem cells are undifferentiated cells able to acquire different phenotypes under specific stimuli. In vitro manipulation of these cells is focused on understanding stem cell behavior, proliferation and pluripotency. Latest advances in the field of stem cells concern epigenetics and its r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruciani, Sara, Santaniello, Sara, Montella, Andrea, Ventura, Carlo, Maioli, Margherita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716083/
https://www.ncbi.nlm.nih.gov/pubmed/31523367
http://dx.doi.org/10.4252/wjsc.v11.i8.464
_version_ 1783447323038187520
author Cruciani, Sara
Santaniello, Sara
Montella, Andrea
Ventura, Carlo
Maioli, Margherita
author_facet Cruciani, Sara
Santaniello, Sara
Montella, Andrea
Ventura, Carlo
Maioli, Margherita
author_sort Cruciani, Sara
collection PubMed
description Mesenchymal stem cells are undifferentiated cells able to acquire different phenotypes under specific stimuli. In vitro manipulation of these cells is focused on understanding stem cell behavior, proliferation and pluripotency. Latest advances in the field of stem cells concern epigenetics and its role in maintaining self-renewal and differentiation capabilities. Chemical and physical stimuli can modulate cell commitment, acting on gene expression of Oct-4, Sox-2 and Nanog, the main stemness markers, and tissue-lineage specific genes. This activation or repression is related to the activity of chromatin-remodeling factors and epigenetic regulators, new targets of many cell therapies. The aim of this review is to afford a view of the current state of in vitro and in vivo stem cell applications, highlighting the strategies used to influence stem cell commitment for current and future cell therapies. Identifying the molecular mechanisms controlling stem cell fate could open up novel strategies for tissue repairing processes and other clinical applications.
format Online
Article
Text
id pubmed-6716083
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-67160832019-09-13 Orchestrating stem cell fate: Novel tools for regenerative medicine Cruciani, Sara Santaniello, Sara Montella, Andrea Ventura, Carlo Maioli, Margherita World J Stem Cells Review Mesenchymal stem cells are undifferentiated cells able to acquire different phenotypes under specific stimuli. In vitro manipulation of these cells is focused on understanding stem cell behavior, proliferation and pluripotency. Latest advances in the field of stem cells concern epigenetics and its role in maintaining self-renewal and differentiation capabilities. Chemical and physical stimuli can modulate cell commitment, acting on gene expression of Oct-4, Sox-2 and Nanog, the main stemness markers, and tissue-lineage specific genes. This activation or repression is related to the activity of chromatin-remodeling factors and epigenetic regulators, new targets of many cell therapies. The aim of this review is to afford a view of the current state of in vitro and in vivo stem cell applications, highlighting the strategies used to influence stem cell commitment for current and future cell therapies. Identifying the molecular mechanisms controlling stem cell fate could open up novel strategies for tissue repairing processes and other clinical applications. Baishideng Publishing Group Inc 2019-08-26 2019-08-26 /pmc/articles/PMC6716083/ /pubmed/31523367 http://dx.doi.org/10.4252/wjsc.v11.i8.464 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Review
Cruciani, Sara
Santaniello, Sara
Montella, Andrea
Ventura, Carlo
Maioli, Margherita
Orchestrating stem cell fate: Novel tools for regenerative medicine
title Orchestrating stem cell fate: Novel tools for regenerative medicine
title_full Orchestrating stem cell fate: Novel tools for regenerative medicine
title_fullStr Orchestrating stem cell fate: Novel tools for regenerative medicine
title_full_unstemmed Orchestrating stem cell fate: Novel tools for regenerative medicine
title_short Orchestrating stem cell fate: Novel tools for regenerative medicine
title_sort orchestrating stem cell fate: novel tools for regenerative medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716083/
https://www.ncbi.nlm.nih.gov/pubmed/31523367
http://dx.doi.org/10.4252/wjsc.v11.i8.464
work_keys_str_mv AT crucianisara orchestratingstemcellfatenoveltoolsforregenerativemedicine
AT santaniellosara orchestratingstemcellfatenoveltoolsforregenerativemedicine
AT montellaandrea orchestratingstemcellfatenoveltoolsforregenerativemedicine
AT venturacarlo orchestratingstemcellfatenoveltoolsforregenerativemedicine
AT maiolimargherita orchestratingstemcellfatenoveltoolsforregenerativemedicine